| ABEO Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the ABEO market cap history going back to 10/24/2014:
Also see: ABEO Shares Outstanding History and ABEO YTD Return |
ABEO Market Cap History — Abeona Therapeutics Capitalization Over Time
As of 5/8/2026 Abeona Therapeutics has a market cap of 336.27 million. Investors often follow the ABEO market cap history to compare the size of the company over time.
This page shows ABEO market capitalization trends over time, with 49 market cap datapoints presented, dating back to 10/24/2014.
| ABEO Market Cap History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ABEO Historical Market Cap: +43.20% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ABEO Stock Price Chart |
| About Abeona Therapeutics Inc |
| Abeona Therapeutics Inc. is a clinical-stage biopharmaceutical company. Co. is engaged in developing cell and gene therapies for life-threatening diseases. Co.'s lead clinical program is for prademagene zamikeracel (pz-cel), its investigational autologous, COL7A1 gene-corrected epidermal sheets currently in development for recessive dystrophic epidermolysis bullosa (RDEB). Co.'s fully integrated cell and gene therapy Good Manufacturing Practice (cGMP) manufacturing facility served as the manufacturing site for pz-cel used in its Phase III VIITAL trial and is capable of supporting commercial production of pz-cel upon FDA approval. We show 49 historical shares outstanding datapoints in our ABEO shares outstanding history coverage, used to compute ABEO market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing ABEO market cap history over the course of time is important for investors interested in comparing ABEO's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of ABEO versus a peer is one thing; comparing ABEO market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like ABEO can fluctuate over the course of history. With this page we aim to empower investors researching ABEO by allowing them to research the ABEO market cap history. |
| ABEO Current Stock Quote |
Quotes delayed 20 minutes  Free ABEO Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: The Importance of Market Cap | |
|
Video: The Importance of Market Cap
| ABEO Share Performance |
| Market Cap Peers |
| Abeona Therapeutics (ABEO) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
ABIO Market Cap History ABMD Market Cap History ABOS Market Cap History ABSI Market Cap History ABT Market Cap History ABVC Market Cap History ACAD Market Cap History ACCD Market Cap History ACER Market Cap History ACET Market Cap History More Healthcare companies » |
ABEO Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
